7R0D | pdb_00007r0d

Structure of NUDT15 in complex with Geranyl monophosphate


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.70 Å
  • R-Value Free: 
    0.226 (Depositor), 0.228 (DCC) 
  • R-Value Work: 
    0.184 (Depositor), 0.197 (DCC) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7R0D

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Kinetic and structural characterization of NUDT15 and NUDT18 as catalysts of isoprene pyrophosphate hydrolysis.

Scaletti, E.R.Unterlass, J.E.Almlof, I.Koolmeister, T.Vallin, K.S.Kapsitidou, D.Tsuber, V.Helleday, T.Stenmark, P.Jemth, A.S.

(2024) FEBS J 

  • DOI: https://doi.org/10.1111/febs.17202
  • Primary Citation Related Structures: 
    7R0D

  • PubMed Abstract: 

    Isoprene pyrophosphates play a crucial role in the synthesis of a diverse array of essential nonsterol and sterol biomolecules and serve as substrates for posttranslational isoprenylation of proteins, enabling specific anchoring to cellular membranes. Hydrolysis of isoprene pyrophosphates would be a means to modulate their levels, downstream products, and protein isoprenylation. While NUDIX hydrolases from plants have been described to catalyze the hydrolysis of isoprene pyrophosphates, homologous enzymes with this function in animals have not yet been reported. In this study, we screened an extensive panel of human NUDIX hydrolases for activity in hydrolyzing isoprene pyrophosphates. We found that human nucleotide triphosphate diphosphatase NUDT15 and 8-oxo-dGDP phosphatase NUDT18 efficiently catalyze the hydrolysis of several physiologically relevant isoprene pyrophosphates. Notably, we demonstrate that geranyl pyrophosphate is an excellent substrate for NUDT18, with a catalytic efficiency of 2.1 × 10 5  m -1 ·s -1 , thus making it the best substrate identified for NUDT18 to date. Similarly, geranyl pyrophosphate proved to be the best isoprene pyrophosphate substrate for NUDT15, with a catalytic efficiency of 4.0 × 10 4  M -1 ·s -1 . LC-MS analysis of NUDT15 and NUDT18 catalyzed isoprene pyrophosphate hydrolysis revealed the generation of the corresponding monophosphates and inorganic phosphate. Furthermore, we solved the crystal structure of NUDT15 in complex with the hydrolysis product geranyl phosphate at a resolution of 1.70 Å. This structure revealed that the active site nicely accommodates the hydrophobic isoprenoid moiety and helped identify key binding residues. Our findings imply that isoprene pyrophosphates are endogenous substrates of NUDT15 and NUDT18, suggesting they are involved in animal isoprene pyrophosphate metabolism.


  • Organizational Affiliation
    • Department of Biochemistry and Biophysics, Stockholm University, Sweden.

Macromolecule Content 

  • Total Structure Weight: 37.79 kDa 
  • Atom Count: 2,683 
  • Modeled Residue Count: 307 
  • Deposited Residue Count: 328 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Probable 8-oxo-dGTP diphosphatase NUDT15A [auth AAA],
B [auth BBB]
164Homo sapiensMutation(s): 0 
Gene Names: NUDT15MTH2
EC: 3.6.1.9 (PDB Primary Data), 3.6.1.76 (UniProt), 3.6.1.68 (UniProt)
UniProt & NIH Common Fund Data Resources
Find proteins for Q9NV35 (Homo sapiens)
Explore Q9NV35 
Go to UniProtKB:  Q9NV35
PHAROS:  Q9NV35
GTEx:  ENSG00000136159 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9NV35
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.70 Å
  • R-Value Free:  0.226 (Depositor), 0.228 (DCC) 
  • R-Value Work:  0.184 (Depositor), 0.197 (DCC) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 46.642α = 90
b = 48.269β = 90
c = 135.197γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
DIALSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
CancerfondenSweden--

Revision History  (Full details and data files)

  • Version 1.0: 2023-11-29
    Type: Initial release
  • Version 1.1: 2024-09-04
    Changes: Database references
  • Version 1.2: 2026-03-04
    Changes: Refinement description, Structure summary